Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cohn

Showing results (671-680 of 730) with videos related to

Pageof 73
Sort By:
Gynecologic Oncology|July 15, 2026
Outcomes following complete response to immune checkpoint inhibitors in endometrial cancerReed M O'Connor, Julia Chalif, Anna Gonzalez, et al.
Health Services Research|December 11, 1999
National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sampleM R Frankel, M F Shapiro, N Duan, et al.
Gynecologic Oncology|April 18, 2013
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancerIsrael Zighelboim, Jason D Wright, Feng Gao, et al.
American Journal of Obstetrics and Gynecology|August 5, 2022
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancerMichelle D S Lightfoot, Ashley S Felix, Corinne A Calo, et al.
Gynecologic Oncology|March 17, 2018
Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP)Emily M Ko, Laura J Havrilesky, Ronald D Alvarez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2007
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experienceW K Huh, J M Straughn, A Mariani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing FrequencyRosie Mngqibisa, Michelle A Kendall, Kelly Dooley, et al.
Contraception|January 14, 2023
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimensKimberly K Scarsi, Laura M Smeaton, Anthony T Podany, et al.
Gynecologic Oncology|April 10, 2023
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomesMonica D Levine, David A Barrington, Caitlin E Meade, et al.
JAMA Oncology|July 22, 2016
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian CancerKatharine M Esselen, Angel M Cronin, Kristin Bixel, et al.
Pageof 73

Showing results (671-680 of 730) with videos related to

Sort By:
Pageof 73
Gynecologic Oncology|July 15, 2026
Outcomes following complete response to immune checkpoint inhibitors in endometrial cancerReed M O'Connor, Julia Chalif, Anna Gonzalez, et al.
Health Services Research|December 11, 1999
National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sampleM R Frankel, M F Shapiro, N Duan, et al.
Gynecologic Oncology|April 18, 2013
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancerIsrael Zighelboim, Jason D Wright, Feng Gao, et al.
American Journal of Obstetrics and Gynecology|August 5, 2022
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancerMichelle D S Lightfoot, Ashley S Felix, Corinne A Calo, et al.
Gynecologic Oncology|March 17, 2018
Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP)Emily M Ko, Laura J Havrilesky, Ronald D Alvarez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2007
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experienceW K Huh, J M Straughn, A Mariani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing FrequencyRosie Mngqibisa, Michelle A Kendall, Kelly Dooley, et al.
Contraception|January 14, 2023
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimensKimberly K Scarsi, Laura M Smeaton, Anthony T Podany, et al.
Gynecologic Oncology|April 10, 2023
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomesMonica D Levine, David A Barrington, Caitlin E Meade, et al.
JAMA Oncology|July 22, 2016
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian CancerKatharine M Esselen, Angel M Cronin, Kristin Bixel, et al.
Pageof 73